Changes observed in radionuclide bone scans during and after teriparatide treatment for osteoporosis

被引：0
|
作者：
Amelia E. B. Moore
Glen M. Blake
Kathleen A. Taylor
Valerie A. Ruff
Asad E. Rana
Xiaohai Wan
Ignac Fogelman
机构：
[1] King’s College London School of Medicine,Department of Nuclear Medicine, Borough Wing; Guy’s Hospital
[2] Eli Lilly and Company and/or one of its subsidiaries,undefined
来源：
European Journal of Nuclear Medicine and Molecular Imaging | 2012年 / 39卷
关键词：
Teriparatide; Tc-MDP bone scan; Bone turnover markers; Bone remodelling; Osteoporosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：326 / 336
页数：10
相关论文
共 50 条
  • [31] Changes in vitamin D metabolites during teriparatide treatment
    Cosman, Felicia
    Dawson-Hughes, Bess
    Wan, Xiaohai
    Krege, John H.
    BONE, 2012, 50 (06) : 1368 - 1371
  • [32] Changes of the quality-of-life under the treatment of severe senile osteoporosis with teriparatide
    Maugeri, Domenico
    Russo, Enzo
    Luca, Salvatore
    Leotta, Carmelo
    Mamazza, Grazia
    Sorace, Rosaria
    Rizzotto, Maurizio
    Manuele, Sara
    Fiore, Valentina
    Taverna, Giuseppe
    Castiglia, Biagio
    Calitro, Michele
    ARCHIVES OF GERONTOLOGY AND GERIATRICS, 2009, 49 (01) : 35 - 38
  • [33] Changes in serum bone markers in relationship to changes in bone mineral density during bisphosphonate treatment in primary osteoporosis
    Armstrong, D. J.
    Hanratty, J.
    Coward, S. M.
    McQuilkin, M.
    Finch, M. B.
    RHEUMATOLOGY, 2007, 46 : I129 - I129
  • [34] Bone loss during treatment for osteoporosis
    不详
    JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 2000, 92 (04) : A15 - A15
  • [35] Changes in bone turnover markers after one year of alendronate treatment in osteoporosis
    Roman, JA
    Fernández, C
    Millán, J
    Fuertes, A
    Abad, L
    Pons, J
    Blasco, M
    Calvo, I
    OSTEOPOROSIS INTERNATIONAL, 2000, 11 : S197 - S197
  • [36] Profile of changes in bone turnover markers during once-weekly teriparatide administration for 24 weeks in postmenopausal women with osteoporosis
    Sugimoto, T.
    Nakamura, T.
    Nakamura, Y.
    Isogai, Y.
    Shiraki, M.
    OSTEOPOROSIS INTERNATIONAL, 2014, 25 (03) : 1173 - 1180
  • [37] Profile of changes in bone turnover markers during once-weekly teriparatide administration for 24 weeks in postmenopausal women with osteoporosis
    T. Sugimoto
    T. Nakamura
    Y. Nakamura
    Y. Isogai
    M. Shiraki
    Osteoporosis International, 2014, 25 : 1173 - 1180
  • [38] Increases in BMD correlate with improvements in bone microarchitecture with Teriparatide treatment in postmenopausal women with osteoporosis
    Chen, Peiqi
    Miller, Paul D.
    Recker, Robert
    Resch, Heinrich
    Rana, Asad
    Pavo, Imre
    Sipos, Adrien A.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 (08) : 1173 - 1180
  • [39] COMPARISON OF BONE DENSITY CHANGES ONE YEAR AFTER TREATMENT WITH ZOLEDRONIC ACID VERSES DAILY TERIPARATIDE
    Aggarwal, A. K.
    Jain, D.
    Aggarwal, N.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1346 - 1346
  • [40] Pain reduction after treatment with teriparatide in 33 patients affected by severe osteoporosis
    Massafra, U.
    Martin, L. S.
    Ragno, A.
    Migliore, A.
    OSTEOPOROSIS INTERNATIONAL, 2007, 18 : S86 - S86
12345